ICS As Rescue Medication in Acute Asthma
No Thumbnail Available
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Asthma guidelines address the issue of acute asthma exacerbation by recommending as the main therapeutic interventions oxygen, inhaled b2-agonists and systemic corticosteroids. These agents are undoubtedly effective, but are also associated with problems such as metabolic adverse effects. Inhaled corticosteroids (ICS) offer potential benefit in the acute setting because they are delivered directly to the airways. They are also likely to reduce systemic exposure, which would lead in turn to reductions in rates of unwanted systemic effects. In this manuscript, data on ICS as recue medication will be evaluated.